• For Patients: Clinical Trials
  • Publications
  • Careers
  • Contact Us
INOVIO Pharmaceuticals
  • About INOVIO
    • Purpose, Mission and Values
    • Leadership
    • Partnerships
  • DNA Medicines Technology
    • Optimized Plasmid Design and Delivery
    • DNA Medicines Explained
    • The Promise of DNA Medicine
    • NEXT GEN DNA MEDICINE
  • DNA Medicines Pipeline
  • Investors & Media
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • FAQ
  • For Patients: Clinical Trials
  • Publications
  • Careers
  • Contact Us
INOVIO Pharmaceuticals
NEWS ALERT

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

  • About INOVIO
    • Purpose, Mission and Values
    • Leadership
    • Partnerships
  • DNA Medicines Technology
    • Optimized Plasmid Design and Delivery
    • DNA Medicines Explained
    • The Promise of DNA Medicine
    • NEXT GEN DNA MEDICINE
  • DNA Medicines Pipeline
  • Investors & Media
    • Events & Presentations
    • Stock Information
    • News Releases
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Shareholder Services
    • FAQ
  • For Patients: Clinical Trials
  • Publications
  • Careers
  • Contact Us

Press Releases

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Posted on August 26, 2025

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

Posted on August 26, 2025

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Posted on August 25, 2025

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Posted on August 25, 2025

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Posted on August 12, 2025

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

Posted on August 12, 2025

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Posted on August 11, 2025

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Posted on August 11, 2025

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Posted on August 4, 2025

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Posted on August 4, 2025
Page 1 of 2012345...1020...»Last »

SUBSCRIBE FOR UPDATES FROM INOVIO
Register to receive email alerts for INOVIO press releases

INOVIO Pharmaceuticals
  • About Inovio
  • DNA Medicines Technology
  • DNA Medicines Pipeline
  • Investors & Media
  • For Patients
  • Publications
  • Careers
  • Contact Us
  • Safe Harbor Statement
  • Expanded Access
  • Privacy Policy
  • Terms & Conditions

© Copyright 2025 INOVIO Pharmaceuticals. All rights reserved.